As part of its modernization effort, the USP has updated several monographs to include ion chromatography (IC) as an analysis ...
COMMACK, NY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced ...
COMMACK, NY - Scienture Holdings, Inc. (NASDAQ:SCNX) announced Tuesday that its Arbli (losartan potassium) Oral Suspension has been added to formularies of key national payors, expanding access to ...
ALBANY, Ore., Nov. 4, 2025 /PRNewswire/ -- Synergy Dental Partners and Oral BioTech are proud to announce a strategic partnership aimed at enhancing oral health care for dental professionals and their ...
The MarketWatch News Department was not involved in the creation of this content. ALBANY, Ore., Nov. 4, 2025 /PRNewswire/ -- Synergy Dental Partners and Oral BioTech are proud to announce a strategic ...
Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Tuesday that Arbli (losartan potassium) Oral Suspension, 10 mg/mL, has been added to the formularies of key national payors, expanding access ...
Scienture Holdings, Inc. (NASDAQ:SCNX), a holding company for existing and planned pharmaceutical operating companies, announced Thursday that it started commercial sales and fulfillment of the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback